Literature DB >> 4729182

Megaloblastic anaemia due to trimethoprim-sulphamethoxazole therapy in uraemia.

G M Yuill.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4729182      PMCID: PMC2495336          DOI: 10.1136/pgmj.49.568.100

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  Folic-acid deficiency in haemolytic anaemia.

Authors:  I CHANARIN; J V DACIE; D L MOLLIN
Journal:  Br J Haematol       Date:  1959-07       Impact factor: 6.998

2.  Sulphamethoxazole-trimethoprim therapy in urinary tract infection with reference to its haematological effects.

Authors:  M E Allison; A C Kennedy; J McGeachie; G A McDonald
Journal:  Scott Med J       Date:  1969-10       Impact factor: 0.729

3.  Effects of trimethoprim on folate metabolism in man.

Authors:  S B Kahn; S A Fein; I Brodsky
Journal:  Clin Pharmacol Ther       Date:  1968 Sep-Oct       Impact factor: 6.875

4.  The haemolytic uraemic syndrome in adults.

Authors:  A R Clarkson; J R Lawrence; R Meadows; A E Seymour
Journal:  Q J Med       Date:  1970-04

5.  Leucopenia associated with trimethoprim-sulphamethoxazole after renal transplantation.

Authors:  B Hulme; D S Reeves
Journal:  Br Med J       Date:  1971-09-11

6.  Serum folate and vitamin B12 levels in acute and chronic renal disease. Effect of peritoneal dialysis.

Authors:  L H Sevitt; A V Hoffbrand
Journal:  Br Med J       Date:  1969-04-05
  6 in total
  2 in total

1.  Toxicity of co-trimoxazole in nutritional haematinic deficiency.

Authors:  A V Hill; D N Kerr
Journal:  Postgrad Med J       Date:  1973-08       Impact factor: 2.401

2.  Assessment of Developmental and Reproductive Fitness of Dengue-Resistant Transgenic Aedes aegypti and Improvement of Fitness Using Antibiotics.

Authors:  Hewawasam Patuwatha Badathuruge Kalindu Dulanja Ramyasoma; Yasanthi Illika Nilmini Silva Gunawardene; Menaka Hapugoda; Ranil Samantha Dassanayake
Journal:  Biomed Res Int       Date:  2021-03-02       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.